PhD in MEDICAL-SURGICAL BIOTECHNOLOGIES AND TRANSLATIONAL MEDICINE

email: adriano.venditti@uniroma2.it
phone: 0620903226
building: torre 6 - piano 9 est
room: 119

Curriculum Vitae
Adriano Venditti

EDUCATION
Medical Degree: obtained at University of Rome la “Sapienza” with maximum mark, 16 October 1986.
Medical license: no. 38245, obtained on 23 March 1987.
Board Certified in Hematology: University of Rome “Tor Vergata” with maximum mark, 24 July 1989.
Fellowships:
1990 “Research Fellow” (National Council Research grant), Dept. Immunology, Royal Free Hospital, London (UK)
1990-91 “Visiting Fellow” Dept. Haematology and Cytogenetics, Royal Marsden Hospital, London (UK)
Quality assurance system auditor for the healthcare sector: July 2007- present.
Master F.A.M.E. (Future Advance in Management Expertise): obtained at SDA Bocconi – School of Management, Jan-March 2012. Management training program for onco-hematologists consisting in 3 in units:
Unit 1: management of “Unità Operative Complesse”.;
Unit 2: diagnostic-therapeutic procedures;
Unit 3: communication skills;

ACADEMIC APPOINTMENTS AND PROFESSIONAL EXPERIENCES
Head of the Department of Onco-Hematology at Fondazione Policlinico Tor Vergata: 2024 – present:
Full Professor of Hematology: 2021-present
Associate Professor of Hematology: Dept. Hematology University "Tor Vergata" of Rome, 2001 - 2021
Director of the Hematology Unit (U.O.S.D.): at Azienda Ospedaliera Universitaria Policlinico Tor Vegata, 2018 – present.
Director of the Hematology Unit (U.O.C.): at Azienda Ospedaliera Universitaria Policlinico Tor Vegata, 2016 – 2018.
Coordinator of the “Diagnostic-therapeutic work-up” unit for Acute Myeloid Leukemia” at Hematology, Fondazione Policlinico Tor Vergata, 2016 – present.
Medical Manager and Head of the research program “Advanced Therapy in Hematology”: at Azienda Ospedaliera Universitaria Policlinico Tor Vegata, 2008 - 2018.
Medical Manager: at Azienda Ospedaliera Universitaria Policlinico Tor Vegata, 2005 – 2008.
Head of the Laboratory for Diagnosis in Hematology: Hematology, Ospedale S.Eugenio, 2003 – 2005.
Assistant Member: Dept. Hematology University "Tor Vergata" of Rome, 1989 – 2001

INVOLVEMENT IN RESEARCH TEAMS AND/OR NATIONAL/INTERNATIONAL SOCIETIES
1. General Secretary of the Italian Society of Hematology Board, 2003 - 2009.
2. Member of the “Acute leukemia Working Party” of “Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA)”, 2009 - present.
3. Elected Member of the Italian Society of Hematology Board, 2010- 2017.
4. Member of the Committee for Educational Activities of the Italian Society of Hematology, 2010 - 2021.
5. Coordinator of the "Writing Committee" of the Italian Society of Hematology for the development of Guidelines for the diagnosis and treatment of Acute Myeloid Leukemia in older patients, 2014 – present.
6. Member of the “Acute Leukemia Group” of the ’European Organization for Research and Treatment of Cancer (EORTC), 2007 – present.
7. Member of the "European LeukemiaNet Work package on minimal residual disease", 2007 - present.
8. Member of the “European LeukemiaNet writing committee” for the development of recommendations on the use of minimal residual disease in acute myeloid leukemia, 2015 - present.
9. Chairman of the “Acute leukemia Working Party” of “Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA)”, 2021 - present.
10. Member of the “Data Safety Monitoring Board” (DSMB) of the European Organization for Research and Treatment of Cancer (EORTC), 2017 – present.
11. Coordinator of the " European LeukemiaNet Writing Committee" for the development of Guidelines for the definition of unfitness in Acute Myeloid Leukemia, 2019 – present.
12. Member of the “Harmony Core Group” established to develop the project entitled “Measurable residual disease as surrogate marker for survival in AML: an individual patient-level correlation”, 2021-present.
13. Member of the “Steering Committee of Siremadlin study” (Novartis), 2021-pesent.
14. Member of the “Steering Committee of VIALE-M study” (Abbvie), 2022-present.
15. Member of the “Steering Committee of ALIDHE study” (Servier), 2022-present.
16. Member of the “Myeloid Steering Committee” (Abbvie), 2023-present.
17. Chairman of the EORTC Acute Leukemia Group 2023-present.
18. Elected Member of the Italian Society of Hematology Board, 2025- 2027

PUBLICATIONS
Three hundred and 8 manuscripts published in peer-reviewed journals.

ID ORCID: 0000-0002-0245-0553
ID SCOPUS: 57827623100
ID RESEARCHER: E-4139-2015

h-index: 51 (Scopus); 48(Web of Science); 56 (ResearchGate); 63 (Google Scholar)
Citations:
Scopus 11530
Web of Science 10958
Google Scholar 16735
ResearchGate 13577